ATRX Share Price Performance
US$0.0001
-0.00 (-95.83%)
Price US$0.0001
Share Pricen/a
Adhera Therapeutics, Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
ATRX Community Narratives
There are no narratives available yet.
There are no community narratives available.
Snowflake Analysis
Adhera Therapeutics, Inc. Key Details
About ATRX
- Founded
- n/a
- Employees
- n/a
- CEO
- WebsiteView website
Adhera Therapeutics, Inc., a biotech company, focuses on the discovery, development, and commercialization of small molecule drugs. The company is developing MLR-1019 for the treatment of Parkinson’s disease; and MLR -1023 to treat Type 1 diabetes. The company was formerly known as Marina Biotech, Inc. and changed its name to Adhera Therapeutics, Inc. in October 2018. Adhera Therapeutics, Inc. is based in Baton Rouge, Louisiana.
